Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tokyo University of Science Innovation Capital (TUSIC) is a venture capital firm based in Tokyo, Japan, serving as the dedicated investment arm of the Tokyo University of Science. The firm specializes in seed and early-stage investments in "deep tech" startups, with a primary focus on life sciences, healthcare, and medical technology. TUSIC aims to bridge the gap between academic research and commercial success by providing financial resources, management expertise, and access to the university's extensive research network. By fostering a robust startup ecosystem, the firm supports the commercialization of cutting-edge technologies that address complex societal and medical challenges. Its portfolio includes ventures working on drug discovery, medical devices, and advanced materials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tokyo University of Science Innovation Capital.